Elite Pharmaceuticals, Inc. Total Long-Term Debt
Elite Pharmaceuticals, Inc. (ELTP) had Total Long-Term Debt of $1.25 million as of 2022-03-31, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2022-11-14
- 2022-03-31: Long-term Debt $1.25M; Long-term Debt as first filed $1.36M.
- 2021-03-31: Long-term Debt $1.47M.
- 2020-03-31: Long-term Debt $1.57M.
- 2014-09-30: Long-term Debt $568.77K.
| Period end | Long-term Debt | Long-term Debt as first filed |
|---|---|---|
| 2022-03-31 | $1.25M 10-Q · filed 2022-11-14 | $1.36M 10-K · filed 2022-06-29 |
| 2021-03-31 | $1.47M 10-K · filed 2021-06-14 | |
| 2020-03-31 | $1.57M 10-K · filed 2020-06-29 | |
| 2014-09-30 | $568.77K 10-Q · filed 2014-11-14 | |
| 2014-03-31 | $106.44K 10-Q · filed 2014-11-14 |